BSE filing, NSE: NECLIFE. Summary written from the filing by ALFA Finder's alert engine.
Nectar Lifesciences Ltd: key numbers
- Share price
- ₹10.34
- Market cap
- ₹231.9 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-292.9 Cr
- P/E (TTM)
- -0.9×Sector 46.1×
- Promoter holding
- 51.84%+0.00% QoQ
- FII holding
- 0.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nectar Lifesciences Ltd
All →Nectar Lifesciences Other Announcement
Nectar Lifesciences Ltd has filed its quarterly shareholding pattern as per SEBI regulations. The document details the promoter group and public shareholding for the quarter.
Nectar Lifesciences Annual General Meeting
Nectar Lifesciences Limited submitted the minutes of its 31st Annual General Meeting held on September 18, 2026. Shareholders approved financial statements and the re-appointment of directors.
Nectar Lifesciences Legal & Regulatory
Nectar Lifesciences provided an update on a material tax litigation where the High Court remanded the matter to the Appellate Authority for fresh consideration.
Nectar Lifesciences Management Change
Nectar Lifesciences Limited has announced the appointment of Dr. Gunmala Suri as a Director. Additionally, three other directors have been re-appointed to the Board.
Nectar Lifesciences Annual General Meeting
Nectar Lifesciences filed proceedings of its 31st AGM held September 18, 2026. Resolutions covered adoption of FY26 financials and director re-appointments.
Nectar Lifesciences Annual Report
Nectar Lifesciences Ltd. has released its Annual Report for FY 2025-26. The 31st Annual General Meeting is scheduled for September 18, 2026, via video conferencing.
Other business update announcements
All →Hero MotoCorp Business Update
Hero MotoCorp updated its code of practices for fair disclosure of unpublished price-sensitive information, effective 28 October 2026. The revised code governs disclosure, spokespersons and analyst interactions.
Cybele Industries Business Update
Cybele Industries disclosed joint venture discussions with a third party, still at an initial stage. No agreement has been executed and no value is stated.
Dr. Reddy's Laboratories Business Update
Dr Reddy's says USFDA closed its PAI and GMP inspection at Srikakulam FTO-SEZ Process Unit-02 with VAI classification. The outcome is closed with no monetary penalty.
Vascon Engineers Business Update
Vascon Engineers awarded Neobridge Realty LLP a Rs.72 Crore shell and core work contract over 25 months. The contract is excluding GST and is described as ordinary course of business.
- Value
- ₹72.00 Cr
- Execution
- 25 months
Meesho Business Update
Meesho's Q2 FY27 shareholders' letter reports NMV up 23% YoY to ₹12,911 crore. Festive timing moved the Mega Blockbuster Sale into Q3.
Dhruv Consultancy Services Business Update
Dhruv Consultancy received an empanelment letter of intent for DPR work for Chhattisgarh government departments, valid for 36 months. No contract value or allotted work was disclosed.
- Execution
- 36 months